ATAK, F. Et Al. 2023. Rhombencephalitis and longitudinal extensive myelitis associated with dinutuximab use in high-risk neuroblastoma. Turkish Journal of Pediatrics , vol.65, no.3 , 523-530.

ATAK, F., AYDIN, G. B., Öncel, İ., Öz, S., & KARLI OĞUZ, H. K., (2023). Rhombencephalitis and longitudinal extensive myelitis associated with dinutuximab use in high-risk neuroblastoma. Turkish Journal of Pediatrics , vol.65, no.3, 523-530.

ATAK, FIRAT Et Al. "Rhombencephalitis and longitudinal extensive myelitis associated with dinutuximab use in high-risk neuroblastoma," Turkish Journal of Pediatrics , vol.65, no.3, 523-530, 2023

ATAK, FIRAT Et Al. "Rhombencephalitis and longitudinal extensive myelitis associated with dinutuximab use in high-risk neuroblastoma." Turkish Journal of Pediatrics , vol.65, no.3, pp.523-530, 2023

ATAK, F. Et Al. (2023) . "Rhombencephalitis and longitudinal extensive myelitis associated with dinutuximab use in high-risk neuroblastoma." Turkish Journal of Pediatrics , vol.65, no.3, pp.523-530.

@article{article, author={FIRAT ATAK Et Al. }, title={Rhombencephalitis and longitudinal extensive myelitis associated with dinutuximab use in high-risk neuroblastoma}, journal={Turkish Journal of Pediatrics}, year=2023, pages={523-530} }